港股異動 | 歐舒丹漲超18%,績後獲多家投行看好
uSMART盈立智投1月27日消息,週三港股早盤,歐舒丹(973 HK)高開高走,截至11:46分,歐舒丹漲超18%,最高觸及23港元,股價升至2015年7月以來最高。
花旗:上調歐舒丹目標價至22港元,評級"買入"
花旗發表研究報告,指出歐舒丹2021財年第三季的收入按年反彈4.3%,有別於第二財季錄4.5%跌幅,符合該行預期。亞洲地區表現強勁,中國、日本及韓國分別按年增長28.9%、10.6%及50%以上。
該行引述管理層指,考慮到亞洲地區表現強勁,及歐洲地區陷入困境,預期第三財季的趨勢將持續至第四財季。
該行將公司的2021財年預測微調,並將2022至2023財年的純利預測上調5%,以反映更高的經營利潤率預期。目標價由原來的19港元上調至22港元,維持"買入"投資評級。
Jefferies:上調該股目標價至26港元
Jefferies分析師Anne Ling等人在報告中表示,上調歐舒丹2021財年淨利潤預測27.6%,因毛利恢復;上調該股目標價至26港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.